Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Correction to: 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Lata.
Adv Ther. 37(5), 2572-2573.
(2020). Twenty-four-hour intraocular pressure control with the travoprost/timolol maleate fixed combination compared with travoprost when both are dosed in the evening in primary open-angle glaucoma..
Br J Ophthalmol. 93(4), 481-5.
(2009). Compliance and viewpoint of glaucoma patients in Greece..
Eye (Lond). 14 Pt 5, 752-6.
(2000). Latanoprost/timolol fixed combination for the treatment of glaucoma..
Expert Opin Pharmacother. 14(13), 1815-27.
(2013). Peak intraocular pressure and glaucomatous progression in primary open-angle glaucoma..
J Ocul Pharmacol Ther. 28(1), 26-32.
(2012). 24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma..
Br J Ophthalmol. 97(7), 857-61.
(2013).
(2017). 24-hour efficacy of travoprost/timolol BAK-free versus latanoprost/timolol fixed combinations in patients insufficiently controlled with latanoprost..
Adv Ther. 31(6), 592-603.
(2014). 24-hour intraocular pressure and blood pressure levels with latanoprost/timolol fixed combination versus timolol..
Curr Eye Res. 34(5), 369-77.
(2009). Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma..
Acta Ophthalmol. 87(1), 71-6.
(2009). Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucoma..
Br J Ophthalmol. 94(2), 209-13.
(2010). Open-angle glaucoma and ocular perfusion..
Br J Ophthalmol. 94(10), 1273-4.
(2010). 24-h Intraocular pressure control with evening-dosed travoprost/timolol, compared with latanoprost/timolol, fixed combinations in exfoliative glaucoma..
Eye (Lond). 24(10), 1606-13.
(2010). Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension..
Br J Ophthalmol. 97(12), 1510-5.
(2013). Comparison of 24-hour intraocular pressure reduction obtained with brinzolamide/timolol or brimonidine/timolol fixed-combination adjunctive to travoprost therapy..
J Ocul Pharmacol Ther. 29(7), 652-7.
(2013). Overview of the [corrected] travoprost /timolol BAK-free fixed combination..
Expert Opin Pharmacother. 13(5), 757-66.
(2012). Epidemiology of Exfoliation Syndrome..
J Glaucoma. 27 Suppl 1, S4-S11.
(2018). Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients..
Expert Opin Pharmacother. 19(18), 1981-1988.
(2018). Prostaglandin-timolol fixed combinations efficacy: myth or reality?.
Eur J Ophthalmol. 22(1), 1-4.
(2012). Twenty-four hour efficacy with the dorzolamide/timolol-fixed combination compared with the brimonidine/timolol-fixed combination in primary open-angle glaucoma..
Eye (Lond). 26(1), 80-7.
(2012). The effect of antifreeze glycoproteins on survival of fish spermatozoa under the conditions of long-term storage.
Biology Bulletin of the Russian Academy of Sciences. 29(1), 75 - 79.
(2002). Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma..
Am J Ophthalmol. 131(6), 729-33.
(2001). 24-hour intraocular pressure control with maximum medical therapy compared with surgery in patients with advanced open-angle glaucoma..
Ophthalmology. 113(5), 761-5.e1.
(2006). High prevalence of BRCA1 founder mutations in Greek breast/ovarian families..
Clin Genet. 85(1), 36-42.
(2014).
(2013).